Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus.

Abstract

Objective Few studies have focused on the efficacy and safety of low-dose of selective sodium glucose transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes. Ipragliflogin is an SGLT2 inhibitor licensed in Japan for administration at standard (50mg/day) or high (100mg/day) doses to treat type 2 diabetes mellitus in Japan. However, little is known about low-dose ipragliflozin (25mg/day) on safety and efficacy on the glucose control parameters and the other metabolic parameters. We study the efficacy and safety of low-dose ipragliflozin for the treatment of diabetic patients. Methods 14 individuals with type 2 diabetes mellitus who had not used SGLT2 inhibitors were recruited and given low-dose ipragliflozin (25mg/day). After 24 weeks, glucose control parameters and the other metabolic parameters were evaluated. Results All patients completed the study without any complications. Compared to baseline, HbA1c, fasting glucose, and HOMA-β significantly improved, and in terms of metabolic parameters, body weight, systolic blood pressure, LDL-cholesterol, and BNP significantly improved. In addition, urinary albumin excretion significantly reduced among the patients with microalbuminuria, and for one patient with macroalbuminuria, urinary albumin excretion decreased to half compared to baseline. Conclusion Low-dose ipragliflozin (25mg/day) is useful for treatment for type 2 diabetes mellitus on not only glycemic control but also the other metabolic disorders without complications of SGLT2 inhibitors.

Authors and Affiliations

Ichiro Abe

Keywords

Related Articles

Association of susceptibility to eating behavior with hemoglobin concentration in females

Background There is an increase in the prevalence of eating disorders in developing countries including India. Young females were reported to be at risk of eating disorders. Hematological complications including anemia w...

Effectiveness of planned teaching programme on knowledge regarding suicidal behavior and its management among PUC students of selected PUC colleges at Vijayapur

Background Knowledge of suicidal behaviour and its management among PUC students is believed to be an important determinant of health seeking behaviour as well as adherence to preventive measures. Aims and objectives The...

Correlates of antenatal care services utilization at health centres in Chandigarh Tricity, India

Background and Aims Adequate and good quality antenatal care (ANC) can ensure a favourable pregnancy outcome, but the coverage of ANC in India remains inadequate. To assess the correlates of antenatal care services utili...

Phytochemical and pharmacological aspect of Amaranthus Tricolor linn Review

Mother Nature has bestowed us with a wide range of flora and fauna which are being used in various systems of medicine to treat various deadly diseases with their own mechanism or the components responsible for healing....

A case report on Pre-B Acute Lymphoblastic Leukemi

Lymphoid leukemias are a group of leukemias affecting circulating lymphocytes. Acute lymphoblastic leukemia (ALL) is a malignant disease of the bone marrow in which early lymphoid precursors proliferate and replace the n...

Download PDF file
  • EP ID EP419806
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Ichiro Abe (2016). Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus.. International Journal of Allied Medical Sciences and Clinical Research, 4(3), 376-382. https://europub.co.uk./articles/-A-419806